|
1 |
14 11 2025 |
Botswana becomes 18th country to recognize IP as book of standards for medicines |
Pharmabiz |
India |
|
2 |
14 11 2025 |
IPC signs MoU with TNPC to promote safe and rational use of medicines |
Pharmabiz |
India |
|
3 |
14 11 2025 |
$100 billion trade target by 2030:India,Russia discuss ways to boost bilateral ties;marine and pharma products in focus |
Times of India |
India |
|
4 |
14 11 2025 |
Akums Drugs & Pharma to Invest $24 Million in Zambian Healthcare Subsidiary |
Scanx Trade |
India |
|
5 |
14 11 2025 |
Schedule M norms: Himachal pharma units stare at deadline crisis |
Tribune |
India |
|
6 |
14 11 2025 |
Pharma Event: CPHI & PMEC India 2025 |
Rediff.com |
India |
|
7 |
13 11 2025 |
Health ministry notifies recruitment rules for drug inspectors post in CDSCO |
Pharmabiz |
India |
|
8 |
13 11 2025 |
Karnataka pharma in compliance mode for revised Schedule M |
Pharmabiz |
India |
|
9 |
13 11 2025 |
NABL launches biobanking accreditation programme to assure quality of biological resources in India |
Pharmabiz |
India |
|
10 |
12 11 2025 |
Goa PMRU sensitises public on the role of NPPA & State PMRU in price control & affordable medicines |
Pharmabiz |
India |
|
11 |
12 11 2025 |
CDSCO alert on toxic syrup forces Haryana SDC to expand quality vigil |
Pharmabiz |
India |
|
12 |
12 11 2025 |
BDCDA protests against GSK’s circular on return of expired/unused drugs within 30 days of expiry |
Pharmabiz |
India |
|
13 |
12 11 2025 |
Parliamentary Panel asks DoP to conduct policy review on TMR approach |
Pharmabiz |
India |
|
14 |
12 11 2025 |
BASF and Beyond Suncare welcome WHO decision to list broad-spectrum sunscreen as “Essential Medicine” |
India Pharma Post |
India |
|
15 |
12 11 2025 |
NATCO Pharma acquire 35.75% stake in Adcock Ingram for USD 226 million |
Medical Dialogues |
India |
|
16 |
12 11 2025 |
Indian pharma makes inroads in China: Cipla, Natco Pharma, Hetero Labs chosen to supply key generic drugs |
UpStox |
India |
|
17 |
11 11 2025 |
Panel recommends DoP to consider better control over prices of non-scheduled formulations |
Pharmabiz |
India |
|
18 |
11 11 2025 |
Indian drug regulators should show zero tolerance on quality issues as patient safety is non-negotiable: Dr Jagashetty |
Pharmabiz |
India |
|
19 |
11 11 2025 |
Ayush and herbal products exports decline 3.3% in H1FY26 |
Pharmabiz |
India |
|
20 |
11 11 2025 |
IP gets recognition as book of standards in 17 countries since 2019 to boost pharma exports |
Pharmabiz |
India |
